Video

Dr. Abraham on Potential Symptoms of TGCT

John A. Abraham, MD, FACS, discusses potential symptoms of tenosynovial giant cell tumor.

John A. Abraham, MD, FACS, founder, Orthopaedic Oncology Service, Rothman Orthopaedic Institute, and attending surgeon, Orthopaedic Surgery, Fox Chase Cancer Center, discusses potential symptoms of tenosynovial giant cell tumor (TGCT).

TGCT can occur within or outside any joint. Therefore, the symptoms of TGCT are based on where the disease occurs, says Abraham.

The synovium of the affected joint will become thick and friable, causing it to break apart, says Abraham. Moreover, as the synovium breaks down, significant bleeding into the affected area can lead to swelling, irritation, and pain.

Joint swelling can result in loss of range of motion and stiffness, explains Abraham. While these symptoms are typically intermittent, they can come on suddenly and without incidental damage to the joint.

Additionally, chronic symptoms such as the disease eroding into the bone are often experienced by patients with TGCT and can cause long-term pain , concludes Abraham.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD